| Literature DB >> 12085234 |
Tomoyuki Saeki1, Abner Mhashilkar, Xin Swanson, X Helena Zou-Yang, Kerry Sieger, Shinichiro Kawabe, Cynthia D Branch, Louis Zumstein, Raymond E Meyn, Jack A Roth, Sunil Chada, Rajagopal Ramesh.
Abstract
Overexpression of the melanoma differentiation associated gene-7 (mda-7) in vitro results in suppression of lung cancer cell proliferation. However, the ability of MDA-7 to suppress lung cancer in vivo has not been previously demonstrated. In this study, we investigated the possibility of inducing overexpression of the mda-7 gene in human non-small cell lung carcinoma cells in vivo and its effects on tumor growth. Adenovirus-mediated overexpression of MDA-7 in p53-wild-type A549 and p53-null H1299 subcutaneous tumors resulted in significant tumor growth inhibition through induction of apoptosis. In addition, decreased CD31/PECAM expression and upregulation of APO2/TRAIL were observed in tumors expressing MDA-7. In vivo studies correlated well with in vitro inhibition of lung tumor cell proliferation and endothelial cell differentiation mediated by Ad-mda7. These data demonstrate that Ad-mda7 functions as a multi-modality anti-cancer agent, possessing both, pro-apoptotic and anti-angiogenic properties. We demonstrate for the first time the potential therapeutic effects of Ad-mda7 in human lung cancer.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12085234 DOI: 10.1038/sj.onc.1205553
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867